Skip to main content
OpenTrials

Clinical trial condition

Primary hyperoxaluria type 1

Explore clinical trials studying Primary hyperoxaluria type 1. Study availability and eligibility vary by location and protocol.

19 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Primary hyperoxaluria type 1 trial results

Recruiting

Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 (redePHine)

NCT06839235

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +13 more
Locations
  • Mayo Clinic Rochester, Minnesota, United States
  • Nucleus Network Saint Paul, Minnesota, United States
  • Hospices Civils de Lyon- Hôpital Femmes Mères Enfants Lyon, France
  • Kindernierenzentrum Bonn Bonn, Germany
View Trial Details
Recruiting

Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD

NCT04580420

Conditions
Chronic Disease, Disease Attributes, End Stage Renal Disease, +13 more
Locations
  • Clinical Trial Site San Francisco, California, United States
  • Clinical Trial Site Boston, Massachusetts, United States
  • Clinical Trial Site Rochester, Minnesota, United States
  • Clinical Trial Site New York, United States
View all 18 locations
View Trial Details
Recruiting

Retrospective and Prospective Follow-up of Patients With Primary Hyperoxaluria Type 1 Treated With Lumasiran in France.

NCT06225882

Conditions
Patients With PH1 Treated With Lumasiran in France, Primary hyperoxaluria type 1
Locations
  • CHU de Besançon Besançon, France
  • Centre de Référence des Maladies Rénales Rares - Hospices Civils de Lyon - Service de Néphrologie et Rhumatologie Pédiatriques - Hôpital Femme Mère Enfant Bron, France
  • Hopital Edouard Herriot Lyon, France
  • AP-HM - Timone Enfants Marseille, France
View Trial Details
Completed

Nedosiran in Pediatric Patients From Birth to 11 Years of Age With PH and Relatively Intact Renal Function

NCT05001269

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +17 more
Locations
  • Clinical Research Site Rochester, Minnesota, United States
  • Clinical Research Site Hamilton, Ontario, Canada
  • Clinical Trial Site Bonn, Germany
  • Clinical Research Site Heidelberg, Germany
View all 13 locations
View Trial Details
Completed

A Study to Evaluate Lumasiran in Patients With Advanced Primary Hyperoxaluria Type 1

NCT04152200

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +14 more
Locations
  • Clinical Trial Site Rochester, Minnesota, United States
  • Clinical Trial Site Houston, Texas, United States
  • Clinical Trial Site Garran, Australia
  • Clinical Trial Site Brussels, Belgium
View all 14 locations
View Trial Details
Completed

A Study of Lumasiran in Infants and Young Children With Primary Hyperoxaluria Type 1

NCT03905694

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +14 more
Locations
  • Clinical Trial Site Rochester, Minnesota, United States
  • Clinical Trial Site Houston, Texas, United States
  • Clinical Trial Site Lyon, France
  • Clinical Trial Site Paris, France
View Trial Details

Related conditions